Companies / Beyang Therapeutics
Beyang Therapeutics
Shanghai, China
Beyang Therapeutics is an innovative biopharmaceutical company that employs its proprietary ExCEED platforms to accelerate the process of new drug discovery and development in disease areas of significant unmet medical needs.
Beyang Therapeutics, based in Shanghai, China, has 1 investor on file, among them Legend Capital. Its latest round on record is Series A, 12 Aug 2026. Its site was last checked 16 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Legend Capital
11 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (55%), Robotics & Hardware (18%), Mobility & Logistics (18%).
See Legend Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Beyang Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Legend Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/beyangtx.com/investors
# also
GET /v1/companies/beyangtx.com
GET /v1/companies/beyangtx.com/news